-
1. Melanoma cell adhesion molecule expressing helper T cells in CNS inflammatory demyelinating diseases. Neurology Neuroimmunology and Neuroinflammation; DOI: https://doi.org/10.1212/NXI.0000000000001069.2021
Ryotaro Ikeguchi, Yuko Shimizu, Kondo Akihiko, Kanda Natsuna, So Hayato, Kojima Haruka and Kazuo Kitagawa.
-
2. Paraneoplastic AQP4-IgG-seropositive NMOSD associated with teratoma: A case report and literature review.Neurology Neuroimmunology and Neuroinflammation.;8:e1045. doi:10.1212/NXI.0000000000001045.2021
Ryotaro Ikeguchi, Yuko Shimizu, Ayato Shimomura, Miki Suzuki, Kanoko Shimoji, Takashi Motohashi, Tomoko Yamamoto, Noriyuki Shibata, and Kazuo Kitagawa.
-
3. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas. Multiple Sclerosis and Related Disorders. 26:77-84.2018
Ikeguchi R, Shimizu Y, Abe K, Shimizu S, Maruyama T , Nitta M, Abe K, Kawamata T, Kitagawa.
-
4. CSF and clinical data distinguish CNS inflammatory demyelinating disease from CNS lymphoma. Mult Scler. 24: 1212-1223.2018
Ikeguchi R, Shimizu Y, Shimizu S, Kitagawa K.
-
5. Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder. Mult Scler. 22:1413-1420.2016
Shimizu Y, Fujihara K, Ohashi T, Nakashima I, Yokoyama K, Ikeguch R, Takahashi T, Misu T, Shimizu S, Aoki M, Kitagawa K.
-
6. Outcomes of pregnancy during interferon beta-1a therapy in Japanese patients with multiple sclerosis: interim results of a postmarketing surveillance study. Clinical and Experimental Neuroimmunology. 6 :402?408.2015
Shimizu Y, Makioka H, Harada N, Nakabayashi S, Saida T. Kira JI.
-
7. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.Journal of Neuroimmunology .263:148-151.2013
Shimizu Y,Ota K, Kubo S, Kabasawa C, Ikeguchi R, Uchiyama S.
-
8. Therapeutic efficacy of interferon beta-1b in Japanese patients with optic-spinal multiple sclerosis (OSMS). The Tohoku Journal of Experimental Medicine. 223 : 211-214.2011
Shimizu Y, Fujihara K, Kubo S, Takahashi T, Misu T, Nakashima I, Yokoyama K, Itoyama Y and Uchiyama S.
-
9. Association of Th1/Th2-related chemokine receptors in peripheral T cells with disease activity in patients with multiple sclerosis and neuromyelitis optica. European Neurology.66;91-97.2011
Shimizu Y, Ota K, Kubo S, Kabasawa C, Kobayashi M, Ohashi T, Uchiyama S.
-
10. High-priced drugs or multiple sclerosis and medical economy in Japan. Clinical and Experimental Neuroimmunology.8 ;289−291.2017
Shimizu Y.
-
11. When and how disease- modifying drugs for multiple sclerosis should be changed in daily practice. Clinical and Experimental Neuroimmunology. 8: 71−80.2017
Shimizu Y, Ikeguchi R, Kitagawa K.
-
12. Management of myasthenia gravis in pregnancy. Clinical and Experimental Neuroimmunology. 7:199−204. 2016
Shimizu Y, Kitagawa K.
-
13. The management for multiple sclerosis and neuromyelitis optica in pregnancy and childbearing. Clinical and Experimental Neuroimmunology. 6 :93?98.2015
Shimizu Y.
-
14. Japanese Guidelines for Fingolimod in MS: putting into practice. Clinical and Experimental Neuroimmunology 5:34-48.2014
Matsui M, Shimizu Y, Doi H, Tomioka R, Nakashima I, Niino M, Kira J-I.
-
15. 脱髄性疾患の妊娠・授乳中の治療指針. 日本臨床 79 (10) :1623-1630.2021
日本臨床 79 (10) :1623-1630
-
16. MS/NMO 女性患者への診療アプローチ. Annual Review 神経 2021 283-293頁 中外医学社.
Annual Review 神経 2021 283-293頁 中外医学社
-
17. 6.エイジング 8 多発性硬化症、視神経脊髄炎。 Clinical Neuroscience 39:99-102.2021
清水優子、藤原一男.
-
18. 43. 自己免疫性神経疾患治療薬、妊娠と授乳 改訂3版 563-572頁.2020
-
19. 性差医療(6)免疫性神経疾患:妊娠・出産のマネージメント.東京女子医大学会誌.89:115-126.2019
清水優子.
-
20. 医事新報 質疑応答プロからプロへ「多発性硬化症患者の妊娠・出産時の治療について」.日本医事新報 No.4970:46-47.2019
清水優子.
-
21. 免疫抑制薬投与中の患者管理について.神経治療学.36:422-427.2019
清水優子.
-
22. 妊娠・出産における注意事項について教えてください.MG Frontier. 1:30-31.2019
清水優子.
-
23. NMO-SDにおける血清Leptin. 神経内科. 90:72-77.2019
清水優子.
-
24. 多発性硬化の最前線 妊娠・出産と就労.Pharma Medica. 36:59-63.2018
清水優子.
-
25. ここに注目!知っているようで知らない疾患のガイセツ 視神経脊髄炎関連疾患. Credentials.115:12-13.2018
清水優子.
-
26. 「多発性硬化症・視神経脊髄炎 診療ガイドライン2017 追加情報‐フマル酸ジメチル‐」(監修日本神経学会、編集 多発性硬化症・視神経脊髄炎診療ガイドライン作成委員会) 医学書院 (PDF版).2018
清水優子(分担執筆)
-
27. 「多発性硬化症・視神経脊髄炎 診療ガイドライン2017」(監修 日本神経学会、編集 多発性硬化症・視神経脊髄炎診療ガイドライン作成委員会) 医学書院.2017
清水優子(分担執筆)
-
28. A Case of Post-Lyme Disease Syndrome (PLDS) Involving Motor Neuropathy and Myositis . M J Neur. 3: 1-5.2018
Shirai Y, Shimizu Y, Uchiyama Y, Kobayashi M, et al.
-
29. Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurology.255:305-307.2008
Shimizu Y, Yokoyama K, Misu T, Takahashi T, Fujihara K, Kikuchi S, Itoyama Y, Iwata M.
-
30. A case of biopsy-proven leptomeningeal amyloidosis and IVIg-responsive polyneuropathy associated with Ala25Thr transthyretin gene mutation. Amyloid J Protein Folding Disord. 13:37-41.2006
Shimizu Y, Takeuchi M, Matsumura M, Tokuda T, Iwata M.